COHEN RAYMOND W

SEC Form 4 insider trading activity

COHEN RAYMOND W has filed 6 SEC Form 4 filings (7 transaction rows) across 3 companies, including KMTS, RXST, NSPR, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Oct 1, 2026.

On the most recent filing, COHEN RAYMOND W is listed as Director at KESTRA MEDICAL TECHNOLOGIES, LTD. Inside the rolling window, COHEN RAYMOND W reported 1 open-market purchase totaling $200K in KMTS and 1 open-market sale totaling $98K in KMTS. The largest disclosed transaction in the window is a purchase of 10,000 KMTS shares on Mar 26, 2026, worth $200K.

Companies traded

Other insiders at KMTS

Insider Buying

$200K

reported purchases (SEC code P)

Insider Selling

$98K

reported sales (SEC code S)

Companies

3

in the rolling window

Source
KMTSSale$98KOct 1SEC ↗
KMTSPurchase$200KMar 30SEC ↗
Showing 1–2 of 2
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Mar 7, 2025KMTSPurchase$289K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has COHEN RAYMOND W made?

COHEN RAYMOND W has filed 6 SEC Form 4 filings (7 transaction rows) across 3 companies, including KMTS, RXST, NSPR since 2025.

Which companies does COHEN RAYMOND W trade?

COHEN RAYMOND W has filed SEC Form 4 disclosures for 3 companies, including KMTS, RXST, NSPR.

When was COHEN RAYMOND W's most recent SEC Form 4 filing?

COHEN RAYMOND W's most recent SEC Form 4 filing on Tracefour is dated Oct 1, 2026.

What is COHEN RAYMOND W's total buy and sell value in the current window?

Inside the rolling retention window, COHEN RAYMOND W bought $200K and sold $98K based on SEC Form 4 filings.

What was COHEN RAYMOND W's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 10,000 KMTS shares on 2026-03-26, worth $200K, per SEC Form 4 filings.